Chromogenic In Situ Hybridization: A Novel Approach to a Practical and Sensitive Method for the Detection of HER2 Oncogene in Archival Human Breast Carcinoma
- 1 August 2002
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 82 (8) , 1007-1014
- https://doi.org/10.1097/01.lab.0000024360.48464.a4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Evaluating HER2 amplification and overexpression in breast cancerThe Journal of Pathology, 2001
- Chromogenic in Situ HybridizationThe American Journal of Pathology, 2000
- Strong Correlation between Results of Fluorescent In Situ Hybridization and Immunohistochemistry for the Assessment of the ERBB2 (HER-2/neu) Gene Status in Breast CarcinomaLaboratory Investigation, 2000
- Determination of Her-2/Neu Status in Breast Carcinoma: Comparative Analysis of Immunohistochemistry and Fluorescent In Situ HybridizationLaboratory Investigation, 2000
- Real time quantitative PCR.Genome Research, 1996
- Genetic alterations in breast cancerGenes, Chromosomes and Cancer, 1995
- Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer researchBreast Cancer Research and Treatment, 1995
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- DOUBLE MINUTES AND HOMOGENEOUSLY STAINING REGIONS: Gene Amplification in Mammalian CellsAnnual Review of Genetics, 1982